Samsung Bioepis records KRW 314.8 billion sales and continue losses in operating & net profits
Samsung Bioepis(unlisted, subsidiary of Samsung Biologics) achieved KRW 314.8 billion sales last year based on the audit report on March and grew 113.4% up compared to the year before.
The company continued to make negative operating profits of KRW 103.5 billion and negative net profits of KRW 8...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.